[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
January 2016

Vitrectomy for Proliferative Diabetic RetinopathyDoes Anyone Know the Complication Rate?

Author Affiliations
  • 1Charlotte Eye, Ear, Nose, and Throat Associates, Charlotte, North Carolina
JAMA Ophthalmol. 2016;134(1):86-87. doi:10.1001/jamaophthalmol.2015.4597

Assessing the quality of health care delivery has long interested ophthalmologists and guides discussions about informed consent, but with the increased use of electronic health records and the increased scrutiny by payers, more efforts have been devoted to the topic. Measuring quality is difficult, in part, because of the problem of defining benchmarks.1 In this context, the study by Jackson and colleagues2 on outcomes of vitreoretinal surgery for complications of proliferative diabetic retinopathy deserves attention.

First Page Preview View Large
First page PDF preview
First page PDF preview